Form D · Venture Capital Fund
DCVC Bio Opportunity Fund, L.P.
Palo Alto, CA · CIK 0001894360
Offering snapshot reported Nov 18, 2021 · SEC filing
- Reported sold
- Yet to sell Offering amount: $350M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 18, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-421747
Source: Form D, filed Nov 18, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zachary Bogue | Executive |
| John Hamer | Executive |
| Matthew Ocko | Executive |
| Kiersten Stead | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
270 University Avenue
Palo Alto, CA, 94301
Palo Alto, CA, 94301